Novogen Settles Menopause Supplement Suit
The monetary terms of the deal were undisclosed, but Novogen did say it has granted Sante a license to the patent in question. As a result, the privately held Quebec-based company will continue manufacturing and selling its non-soy based isoflavone supplements.
Among other things, isoflavones have been found to reduce such menopause symptoms as hot flashes.
“The resolution of this matter is another...
To view the full article, register now.